| For: | Seo W, Jeong WI. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease? World J Gastroenterol 2016; 22(4): 1348-1356 [PMID: 26819504 DOI: 10.3748/wjg.v22.i4.1348] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i4/1348.htm |
| Number | Citing Articles |
| 1 |
Xue Fan, Qianhui Tang, Ninglin Xia, Jiwei Wang, Wen Zhao, Ming Jin, Qian Lu, Jinyu Hu, Rongmi Zhang, Luyong Zhang, Zhenzhou Jiang, Qinwei Yu. Immune-endothelial cell crosstalk in hepatic endothelial injury of liver fibrotic mice. European Journal of Pharmacology 2025; 1000 doi: 10.1016/j.ejphar.2025.177730
|
| 2 |
Min Liu, Yuting Xiang, Yuqi Yang, Xingyu Long, Zuoxiu Xiao, Yayun Nan, Yitian Jiang, Yige Qiu, Qiong Huang, Kelong Ai. State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC. Biosensors and Bioelectronics 2022; 218 doi: 10.1016/j.bios.2022.114758
|
| 3 |
Nesrine S. El-Mezayen, Wessam F. El-Hadidy, Wessam M. El-Refaie, Thanaa I. Shalaby, Mahmoud M. Khattab, Aiman S. El-Khatib. Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence. Journal of Controlled Release 2018; 283 doi: 10.1016/j.jconrel.2018.05.021
|
| 4 |
Mariia Uzhytchak, Barbora Smolková, Mariia Lunova, Adam Frtús, Milan Jirsa, Alexandr Dejneka, Oleg Lunov. Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function. Advanced Drug Delivery Reviews 2023; 197 doi: 10.1016/j.addr.2023.114828
|
| 5 |
Kiyoon Min, Sathish Kumar Karuppannan, Giyoong Tae. The impact of matrix stiffness on hepatic cell function, liver fibrosis, and hepatocellular carcinoma—Based on quantitative data. Biophysics Reviews 2024; 5(2) doi: 10.1063/5.0197875
|
| 6 |
A. D. Kjaergaard, J. S. Johansen, S. E. Bojesen, B. G. Nordestgaard. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Critical Reviews in Clinical Laboratory Sciences 2016; 53(6) doi: 10.1080/10408363.2016.1190683
|
| 7 |
Arshi Khanam, Paul G. Saleeb, Shyam Kottilil. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?. Cells 2021; 10(5) doi: 10.3390/cells10051097
|
| 8 |
Qun Niu, Yu Mou, Kaixin Wang, Haijian Dong, Zijian Zeng, Hui Li. Natural medicines for treating liver fibrosis by modulating post-translational modifications. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1660908
|
| 9 |
Seol Hee Park, Young-Sun Lee, Jaemin Sim, Seonkyung Seo, Wonhyo Seo. Alcoholic liver disease: a new insight into the pathogenesis of liver disease. Archives of Pharmacal Research 2022; 45(7) doi: 10.1007/s12272-022-01392-4
|
| 10 |
Yuchao Wu, Tianzhi Ni, Mengmeng Zhang, Shan Fu, Danfeng Ren, Yali Feng, Huiping Liang, Ze Zhang, Yingren Zhao, Yingli He, Yuan Yang, Zhen Tian, Taotao Yan, Jinfeng Liu. Treatment with β-Adrenoceptor Agonist Isoproterenol Reduces Non-parenchymal Cell Responses in LPS/D-GalN-Induced Liver Injury. Inflammation 2024; 47(2) doi: 10.1007/s10753-023-01941-z
|
| 11 |
X. Joseph, V. Akhil, A. Arathi, PV. Mohanan. Comprehensive Development in Organ-On-A-Chip Technology. Journal of Pharmaceutical Sciences 2022; 111(1) doi: 10.1016/j.xphs.2021.07.014
|
| 12 |
Natalia Pydyn, Anna Ferenc, Katarzyna Trzos, Ewelina Pospiech, Mateusz Wilamowski, Olga Mucha, Piotr Major, Justyna Kadluczka, Pedro M. Rodrigues, Jesus M. Banales, Jose M. Herranz, Matias A. Avila, Tomasz Hutsch, Piotr Malczak, Dorota Radkowiak, Andrzej Budzynski, Jolanta Jura, Jerzy Kotlinowski. MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis. Cellular and Molecular Gastroenterology and Hepatology 2024; 17(6) doi: 10.1016/j.jcmgh.2024.01.021
|
| 13 |
Ji‐Hua Shi, Pål‐Dag Line. Hallmarks of postoperative liver regeneration: An updated insight on the regulatory mechanisms. Journal of Gastroenterology and Hepatology 2020; 35(6) doi: 10.1111/jgh.14944
|
| 14 |
Qiannan Chen, Chengpan Li, Weiping Ding, Derun Kong. Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review. Advanced Healthcare Materials 2026; 15(5) doi: 10.1002/adhm.202503273
|
| 15 |
Xiao Wang, Bo-Lin Xu, Xiao-Wei Chen. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology. STAR Protocols 2021; 2(3) doi: 10.1016/j.xpro.2021.100611
|
| 16 |
Donggyu Nam, Myung Rae Park, Hyunah Lee, Sung Chul Bae, Daniela Gerovska, Marcos J. Araúzo-Bravo, Holm Zaehres, Hans R. Schöler, Jeong Beom Kim. Induced Endothelial Cell-Integrated Liver Assembloids Promote Hepatic Maturation and Therapeutic Effect on Cholestatic Liver Fibrosis. Cells 2022; 11(14) doi: 10.3390/cells11142242
|
| 17 |
Hyemin Kim, Ilkyun Im, Jang Su Jeon, Eun-Hye Kang, Hyang-Ae Lee, Seongyea Jo, Ji-Woo Kim, Dong-Hun Woo, Young Jae Choi, Hyo Jin Kim, Ji-Seok Han, Byoung-Seok Lee, Jong-Hoon Kim, Sang Kyum Kim, Han-Jin Park. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. Biomaterials 2022; 286 doi: 10.1016/j.biomaterials.2022.121575
|
| 18 |
Nesrine S. El-Mezayen, Wessam F. El-Hadidy, Wessam M. El-Refaie, Th.I. Shalaby, Mahmoud M. Khattab, Aiman S. El-Khatib. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis. Journal of Controlled Release 2017; 266 doi: 10.1016/j.jconrel.2017.09.035
|
| 19 |
Vincent Rönnpagel, Anett Ullrich, Christy Joseph, Mladen V. Tzvetkov, Dieter Runge, Markus Grube. Expression of Selected Pharmacologically Relevant Transporters in Murine Non-Parenchymal Liver Cells Compared to Hepatocytes. International Journal of Molecular Sciences 2025; 26(22) doi: 10.3390/ijms262211116
|
| 20 |
Kangdi Yang, Xiayan Chu, Xuerui Wang, Wenkun Zhang, Jinnuo Lu, Chuting Xu, Shoucheng Hu, Guoyu Pan, Chih‐Tsung Yang, Xiaohui Zhang, Shaojin Li, Zhaobin Guo, Hanyang Liu, Guangbo Ge. Novel Vascularized Human Liver Organoids for Modeling Alcohol‐Induced Liver Injury and Developing Hepatoprotective Therapy. Advanced Science 2026; 13(9) doi: 10.1002/advs.202511169
|
| 21 |
Kusum K. Kharbanda, Shilpa Chokshi, Irina Tikhanovich, Steven A. Weinman, Moses New-Aaron, Murali Ganesan, Natalia A. Osna. A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin. Biology 2023; 12(2) doi: 10.3390/biology12020255
|
| 22 |
K. V. Sokolova, I. G. Danilova. Liver macrophages as the key regulators of tissue homeostasis in organ. Ural Medical Journal 2023; 22(6) doi: 10.52420/2071-5943-2023-22-6-85-93
|
| 23 |
Eleftheria M. Mastoridou, Anna C. Goussia, Georgios K. Glantzounis, Panagiotis Kanavaros, Antonia V. Charchanti. Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis. Frontiers in Physiology 2022; 12 doi: 10.3389/fphys.2021.801340
|
| 24 |
Jiu Deng, Zongzheng Chen, Xiuli Zhang, Yong Luo, Zhengzhi Wu, Yao Lu, Tingjiao Liu, Weijie Zhao, Bingcheng Lin. A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cells. Biomedical Microdevices 2019; 21(3) doi: 10.1007/s10544-019-0414-9
|
| 25 |
Sushila Maharjan, Diana Bonilla, Princy Sindurakar, Hongbin Li, Wanlu Li, Sergio Duarte, Ali Zarrinpar, Y. Shrike Zhang. 3D human nonalcoholic hepatic steatosis and fibrosis models. Bio-Design and Manufacturing 2021; 4(2) doi: 10.1007/s42242-020-00121-4
|
| 26 |
Inês Coelho, Nádia Duarte, Maria Paula Macedo, Carlos Penha-Gonçalves. Insights into Macrophage/Monocyte-Endothelial Cell Crosstalk in the Liver: A Role for Trem-2. Journal of Clinical Medicine 2021; 10(6) doi: 10.3390/jcm10061248
|
| 27 |
Najma Ali, Kevin Ferrao, Kosha J. Mehta. Liver Iron Loading in Alcohol-Associated Liver Disease. The American Journal of Pathology 2023; 193(10) doi: 10.1016/j.ajpath.2022.08.010
|
| 28 |
Veronika Boichenko, Svetlana Frolova, Christine Voellenkle, Germana Zaccagnini, Paolo Ferrero, Pier Paolo Bassareo, Giovanni Battista Luciani, Julia Gorelik, Fabio Martelli. Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis. Biomedicine & Pharmacotherapy 2026; 201 doi: 10.1016/j.biopha.2026.119607
|
| 29 |
Sheng Cao, Mengfei Liu, Tejasav S. Sehrawat, Vijay H. Shah. Regulation and functional roles of chemokines in liver diseases. Nature Reviews Gastroenterology & Hepatology 2021; 18(9) doi: 10.1038/s41575-021-00444-2
|
| 30 |
Sara Mohamed Naguib Abdel Hafez, Rehab Ahmed Rifaai, Asmaa M.A. Bayoumi. Impact of renal ischemia/reperfusion injury on the rat Kupffer cell as a remote cell: A biochemical, histological, immunohistochemical, and electron microscopic study. Acta Histochemica 2019; 121(5) doi: 10.1016/j.acthis.2019.04.008
|
| 31 |
Alka Singh, Ansab Akhtar, Prashant Shukla. Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives. ADMET and DMPK 2025; 13(4) doi: 10.5599/admet.2874
|
| 32 |
Nagwa Ramadan Ahmed, Ahmed Nabil EL-Mazny, Sarah Ahmed Hassan, Laila Ahmed Rashed. Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2019; 31(4) doi: 10.4103/ejim.ejim_63_19
|
| 33 |
Zhongmin Zhou, Cong Li, Zexi Tan, Guoliang Sun, Bo Peng, Tengfei Ren, Jiabei He, Yixue Wang, Yinyan Sun, Fengchao Wang, Wenhui Li. A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus. Antiviral Research 2023; 216 doi: 10.1016/j.antiviral.2023.105642
|
| 34 |
Changwen Zhang, Jillian L. Ellis, Chunyue Yin. Inhibition of vascular endothelial growth factor signaling facilitates liver repair from acute ethanol-induced injury in zebrafish. Disease Models & Mechanisms 2016; 9(11) doi: 10.1242/dmm.024950
|
| 35 |
Hyemin Kim, Han-Jin Park. Current hPSC-derived liver organoids for toxicity testing: Cytochrome P450 enzymes and drug metabolism. Toxicological Research 2025; 41(2) doi: 10.1007/s43188-024-00275-8
|
| 36 |
Hiral Aghara, Prashsti Chadha, Devangi Zala, Palash Mandal. Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1205821
|
| 37 |
Xiaoqiang Qi, Ming Yang, Joseph Stenberg, Rahul Dey, Leslie Fogwe, Muhammad Shawkat Alam, Eric T Kimchi, Kevin F Staveley-O'Carroll, Guangfu Li. Gut microbiota mediated molecular events and therapy in liver diseases. World Journal of Gastroenterology 2020; 26(48): 7603-7618 doi: 10.3748/wjg.v26.i48.7603
|
| 38 |
Kristina Duspara, Kristina Bojanic, Josipa Ivanusic Pejic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Nincevic, Robert Smolic, Aleksandar Vcev, Marija Glasnovic, Ines Bilic Curcic, Martina Smolic. Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2021.00065
|
| 39 |
Yin Zhu, Xiaozhi Wang, Lujian Zhu, Yulu Tu, Wanting Chen, Lingwen Gong, Tongtong Pan, Hongwei Lin, Jing Lin, Huiling Sun, Yuli Ge, Li Wei, Yu Guo, Caide Lu, Yongping Chen, Lanman Xu. Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells. Toxicology and Applied Pharmacology 2022; 439 doi: 10.1016/j.taap.2022.115923
|
| 40 |
Tyler C. Gripshover, Rui S. Treves, Eric C. Rouchka, Julia H. Chariker, Shirong Zheng, Elizabeth Hudson, Melissa L. Smith, Ashwani K. Singal, Craig J. McClain, Josiah E. Hardesty. Visium spatial transcriptomics and proteomics identifies novel hepatic cell populations and transcriptomic signatures of alcohol‐associated hepatitis. Alcohol, Clinical and Experimental Research 2025; 49(1) doi: 10.1111/acer.15494
|
| 41 |
Aleksejs Derovs, Sniedze Laivacuma, Angelika Krumina. Targeting Microbiota: What Do We Know about It at Present?. Medicina 2019; 55(8) doi: 10.3390/medicina55080459
|
| 42 |
Yuki Noguchi, Kazuhisa Ozeki, Hidetaka Akita. Cellular Binding and Internalization Assay for an Anti-FcγRIIB Antibody Using Human Liver Non-parenchymal Cells. Biological and Pharmaceutical Bulletin 2022; 45(4) doi: 10.1248/bpb.b21-01026
|
| 43 |
Joe Jongpyo Lim, Curtis Dean Klaassen, Julia Yue Cui. Deciphering the cell type-specific and zonal distribution of drug-metabolizing enzymes, transporters, and transcription factors in livers of mice using single-cell transcriptomics. Drug Metabolism and Disposition 2025; 53(2) doi: 10.1016/j.dmd.2024.100029
|
| 44 |
Tom Ryu, Kyurae Kim, Sung Eun Choi, Katherine Po Sin Chung, Won-Il Jeong. New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways☆. Liver Research 2023; 7(1) doi: 10.1016/j.livres.2022.09.004
|
| 45 |
Saied Froghi, Matheus Oliveira de Andrade, Layla Mohammad Hadi, Pierre Gelat, Hassan Rashidi, Alberto Quaglia, Barry Fuller, Nader Saffari, Brian Davidson. Liver Ultrasound Histotripsy: Novel Analysis of the Histotripsy Site Cell Constituents with Implications for Histotripsy Application in Cell Transplantation and Cancer Therapy. Bioengineering 2023; 10(2) doi: 10.3390/bioengineering10020276
|
| 46 |
Rupchand Sutradhar, D.C. Dalal. The roles of continuous and discontinuous proliferations on hepatitis B virus infection. Mathematical Biosciences 2025; 385 doi: 10.1016/j.mbs.2025.109448
|
| 47 |
Abdolamir Allameh, Reyhaneh Niayesh-Mehr, Azadeh Aliarab, Giada Sebastiani, Kostas Pantopoulos. Oxidative Stress in Liver Pathophysiology and Disease. Antioxidants 2023; 12(9) doi: 10.3390/antiox12091653
|
| 48 |
Anupriya Tripathi, Justine Debelius, David A. Brenner, Michael Karin, Rohit Loomba, Bernd Schnabl, Rob Knight. The gut–liver axis and the intersection with the microbiome. Nature Reviews Gastroenterology & Hepatology 2018; 15(7) doi: 10.1038/s41575-018-0011-z
|
| 49 |
N. Luo, J. Li, Y. Wei, J. Lu, R. Dong. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiological Research 2021; (6) doi: 10.33549/physiolres.934755
|
| 50 |
Elias Iturrospe, Rani Robeyns, Katyeny Manuela da Silva, Maria van de Lavoir, Joost Boeckmans, Tamara Vanhaecke, Alexander L. N. van Nuijs, Adrian Covaci. Metabolic signature of HepaRG cells exposed to ethanol and tumor necrosis factor alpha to study alcoholic steatohepatitis by LC–MS-based untargeted metabolomics. Archives of Toxicology 2023; 97(5) doi: 10.1007/s00204-023-03470-y
|
| 51 |
Sanghoon Lee, Ping Zhou, Senyo Whyte, Soona Shin. Adeno-Associated Virus Serotype 8-Mediated Genetic Labeling of Cholangiocytes in the Neonatal Murine Liver. Pharmaceutics 2020; 12(4) doi: 10.3390/pharmaceutics12040351
|
| 52 |
Shen Jiayuan, Yan Junyan, Wei Xiangzhen, Liu Zuping, Ni Jian, Hu Baowei, Jin Lifang. Gant61 ameliorates CCl4-induced liver fibrosis by inhibition of Hedgehog signaling activity. Toxicology and Applied Pharmacology 2020; 387 doi: 10.1016/j.taap.2019.114853
|
| 53 |
Young-Ri Shim, Won-Il Jeong. Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease. Experimental & Molecular Medicine 2020; 52(5) doi: 10.1038/s12276-020-0438-5
|
| 54 |
Sumi Sung, Jieun Kim, Youngmi Jung. Liver-Derived Exosomes and Their Implications in Liver Pathobiology. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123715
|
| 55 |
Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong. Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell. Clinical and Molecular Hepatology 2020; 26(4) doi: 10.3350/cmh.2020.0152
|
| 56 |
Yu Hou, Si-Ying Wang, Zi-Yi Xu, Guo Xin, Gui-Yun Zhao, Hai-Ming Sun. Momordicine I, a triterpene from bitter melon (Momordica charantia L.), ameliorates alcohol-associated liver disease: research on the possible liver benefits. Food & Function 2026; 17(4) doi: 10.1039/D5FO05054E
|